1. Home
  2. BSX vs NTES Comparison

BSX vs NTES Comparison

Compare BSX & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$63.44

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Logo NetEase Inc.

NTES

NetEase Inc.

HOLD

Current Price

$118.21

Market Cap

69.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
NTES
Founded
1979
1997
Country
United States
China
Employees
N/A
26028
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
93.4B
69.2B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
BSX
NTES
Price
$63.44
$118.21
Analyst Decision
Strong Buy
Buy
Analyst Count
21
3
Target Price
$102.10
$160.00
AVG Volume (30 Days)
14.5M
535.5K
Earning Date
04-22-2026
05-14-2026
Dividend Yield
N/A
2.56%
EPS Growth
55.20
N/A
EPS
1.94
N/A
Revenue
$9,076,000,000.00
N/A
Revenue This Year
$11.91
$9.57
Revenue Next Year
$10.26
$8.57
P/E Ratio
$33.29
$79.88
Revenue Growth
12.49
N/A
52 Week Low
$60.59
$98.36
52 Week High
$109.50
$159.55

Technical Indicators

Market Signals
Indicator
BSX
NTES
Relative Strength Index (RSI) 38.72 61.08
Support Level $60.59 $111.48
Resistance Level $76.77 $119.94
Average True Range (ATR) 1.80 1.85
MACD 0.46 0.85
Stochastic Oscillator 29.82 88.12

Price Performance

Historical Comparison
BSX
NTES

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About NTES NetEase Inc.

Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.

Share on Social Networks: